<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="from asymptomatic/mild symptoms to severe illness and death. The viral" exact="infection" post="expanded internationally and WHO announced a Public Health Emergency"/>
 <result pre="from around the world to develop a rapid quality diagnosis," exact="treatment" post="and vaccines, but so far no specific antiviral treatment"/>
 <result pre="diagnosis, treatment and vaccines, but so far no specific antiviral" exact="treatment" post="or vaccine has been approved by the FDA. At"/>
 <result pre="pain, sore throat, loss of taste and/or smell [3]. Clinical" exact="diagnosis" post="of COVID-19 is based on clinical manifestations, molecular diagnostics"/>
 <result pre="material that can diagnose an active COVID-19 infection. The early" exact="detection" post="of COVID-19 via PCR depends on the presence of"/>
 <result pre="and the sensitivity of the RT-PCR assay. So, optimized or" exact="screening" post="methods that able to detect the 2019-nCoV even in"/>
 <result pre="the virus, especially IgM which is produced early after the" exact="infection" post="[8]. It seems that serological tests, along with PCR"/>
 <result pre="do not help diagnose and screen in early infection. After" exact="infection" post="with 2019-nCoV, it takes 2 weeks or more for"/>
 <result pre="than immune and serological tests in the diagnose of primary" exact="infection" post="and can accelerate early screening even during the incubation"/>
 <result pre="in the diagnose of primary infection and can accelerate early" exact="screening" post="even during the incubation period of COVID-19 (before symptom"/>
 <result pre="with a positive RT-PCR test and severe, mild, or asymptomatic" exact="infection" post="may still be prone to a second infection. Coronavirus"/>
 <result pre="epithelial cells of the lung and gastrointestinal tract. So, severe" exact="infection" post="may occur in tissues with high expression levels of"/>
 <result pre="and the existence of some degenerated neutrophils indicate the viral" exact="infection" post="in these cells [31]. Megakaryocyte response and platelet production"/>
 <result pre="effects of the virus, and body immune response to viral" exact="infection" post="must be considered in the disease management [34, 35]."/>
 <result pre="cannot be said that it is completely 100% safe. Intestinal" exact="infection" post="and the presence of 2019-nCoV in feces have been"/>
 <result pre="hemorrhagic encephalopathy have been reported in patients with severe COVID-19" exact="infection" post="[69]. Therapeutic results have shown that neurological symptoms gradually"/>
 <result pre="that neurological symptoms gradually decrease in patients receiving viral encephalitis" exact="treatment" post="[70]. About half of patients with COVID-19 show evidence"/>
 <result pre="therapy, antibiotics, corticosteroids, and anti-inflammatory drugs are commonly used in" exact="treatment" post="protocols [79]. Most drug designs against 2019-nCoV have been"/>
 <result pre="helicase, and polymerases [80]. However, to date, no specific antiviral" exact="treatment" post="or vaccine has been approved by the FDA for"/>
 <result pre="and mechanical ventilation. The available therapeutic agents used for the" exact="treatment" post="of COVID-19 patients are antiviral agents including Remdesivir, Chloroquine,"/>
 <result pre="severity of the disease and the duration of the viral" exact="infection" post="[83]. Vitamin D as an adjunctive agent can reduce"/>
 <result pre="have shown that both drugs could be effective against SARS-CoV" exact="infection" post="and prevent from the virus spread [88], but several"/>
 <result pre="Despite the positive reports of this herbal formula in the" exact="treatment" post="of lung diseases in our country, no experimental or"/>
 <result pre="solution [92]. Other examples of herbal medicine used in COVID-19" exact="treatment" post="include: Ginseng (Panax ginseng) regulates the activity of immune"/>
 <result pre="they may still be a virus carrier and spread the" exact="infection" post="to others. Conclusions 2019-nCoV exists in the respiratory, fecal,"/>
 <result pre="for treating COVID-19 or preventing 2019-nCoV infection. Like influenza, the" exact="prevalence" post="of COVID-19 is expected to decrease as the weather"/>
 <result pre="the weather warms up in the summer and the 2019-nCoV" exact="infection" post="is predicted to start again with the gradual cooling"/>
 <result pre="al.Ezrin interacts with the SARS coronavirus Spike protein and restrains" exact="infection" post="at the entry stagePLoS One.2012711e4956623185364 20.HuiDSMemishZAZumlaASevere acute respiratory syndrome"/>
 <result pre="Assay Kit. J Clin Microbiol. 2020;58(6). 24.YanCCuiJHuangLDuBChenLXueGet al.Rapid and visual" exact="detection" post="of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription"/>
 <result pre="and clinical implications. J Med Virol. 2020. 34.FelsensteinSHerbertJAMcNamaraPSHedrichCMCOVID-19: Immunology and" exact="treatment" post="optionsClin Immunol202021510844832353634 35.BeckerRCCOVID-19 update: Covid-19-associated coagulopathyJ Thromb Thrombolysis.2020501546732415579 36.HammingITimensWBulthuisMLCLelyATNavisGJvan"/>
 <result pre="Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and" exact="treatment" post="coronavirus (COVID-19). Statpearls [internet]: StatPearls Publishing; 2020. 53.RiouJAlthausCLPattern of"/>
 <result pre="action. Br J Haematol. 2020;189(5):846-7. 68.WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav Immun.2020S0889â€&quot;1591203035730353 69.Wu X,"/>
 <result pre="clinicoradiologic disorder. Mediators Inflamm. 2015;2015:792578. 70.WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav Immun.202087182232240762 71.Larsen CP,"/>
 <result pre="mutagenesis and error threshold. Quasispecies. 2015:323â€&quot;39. 81.PruijssersAJDenisonMRNucleoside analogues for the" exact="treatment" post="of coronavirus infectionsCurr Opinion Virol2019355762 82.LuHDrug treatment options for"/>
 <result pre="analogues for the treatment of coronavirus infectionsCurr Opinion Virol2019355762 82.LuHDrug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV)Biosci Trends.2020141697131996494 83.HeXLauEHWuPDengXWangJHaoXet al.Temporal"/>
 <result pre="Infect.20209138238532065055 88.VincentMJBergeronEBenjannetSEricksonBRRollinPEKsiazekTGet al.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J200526916115318 89.SinghAKSinghAShaikhASinghRMisraAChloroquine and hydroxychloroquine in the treatment"/>
 <result pre="coronavirus infection and spreadVirol J200526916115318 89.SinghAKSinghAShaikhASinghRMisraAChloroquine and hydroxychloroquine in the" exact="treatment" post="of COVID-19 with or without diabetes: A systematic search"/>
</results>
